alexa
Reach Us +44-1764-910199
Editor - William J Federspiel | University of Pittsburgh | 19967
ISSN: 2472-1247

Journal of Clinical Respiratory Diseases and Care
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

William J Federspiel

William J Federspiel
William J Federspiel
Director
Medical Devices Laboratory
University of Pittsburgh
Pittsburgh
Tel:(412) 383-9499
University of Pittsburgh

Biography

William J Federspiel received doctorate in Chemical Engineering from University of Rochester.He is the Director, Medical Devices Laboratory at University of Pittsburgh since 1995.William J Federspiel is also Founder and Head, Scientific Advisory Board at ALung Technologies, Pittsburgh.His profile strength includes over 100 peer reviewed journal articles published and over 100 proceedings and abstracts.

Research Interest

1. Design and development of novel artificial lung devices, including respiratory support catheters and paracorporeal assist lungs, for near term clinical use in the treatment of respiratory failure in patients with acute or acute on chronic lung insufficiencies.
2. Design and development of membrane and particle based blood purification devices for the selective or semi-selective and patterned removal of pathogenic antibodies, inflammatory mediators, and other blood borne solutes for near term clinical use in critical care settings.
3. Advancing the development of novel artificial lung platforms for future applications by combining microfabrication and fiber technology with cellular and biomolecular components to create biohybrid artificial alveolar capillary units and bioactive hollow fibers with improved gas exchange efficiency and capacity.

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7
Top